BOAN BIOTECH News

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Aug 5 14:14

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTAPPROVAL OBTAINED FOR INITIATING CLINICAL TRIALSFOR DULAGLUTIDE INJECTION (BA5101) IN THE U.S.

Aug 5 12:01

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTAPPROVAL OBTAINED FOR INITIATING CLINICAL TRIAL FORTHE NOVEL ADC CANDIDATE BA1302 IN CHINA

Jul 25 16:41

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTACCEPTANCE OF BLA IN CHINA FORAFLIBERCEPT INTRAVITREOUS INJECTION (BA9101)

Jul 16 19:00

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 2 17:58

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 4 11:08

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTACCEPTANCE OF BLA IN CHINA FORDULAGLUTIDE INJECTION (BA5101)

May 27 20:54

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTDENOSUMAB INJECTION (BOLUOJIA) FOR ONCOLOGYINDICATIONS APPROVED FOR MARKETING BY NMPA

May 27 12:06

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 6 11:17

BOAN BIOTECH: FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 31 MAY 2024 (APPLICABLE TO HOLDERS OF H SHARES)

Apr 29 22:29

BOAN BIOTECH: 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT

Apr 29 22:27

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTPHASE 3 CLINICAL TRIAL COMPLETED IN CHINA FOR AFLIBERCEPT INTRAVITREOUS INJECTION (BA9101) AND BLA TO BE FILED

Apr 8 16:31

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 8 11:49

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTPHASE 3 CLINICAL TRIAL COMPLETED IN CHINA FORDULAGLUTIDE INJECTION (BA5101) AND BLA TO BE FILED

Mar 8 12:28

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 1 11:17

BOAN BIOTECH: Notification Letter to Non-registered H Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications

Feb 29 19:44

BOAN BIOTECH: Notification Letter to Registered H Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications

Feb 29 19:43

BOAN BIOTECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 1 12:29

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTAUTHORIZATION TO ZENCORE BIOLOGICS TO USE BA-HIEXCELLSTABLE CELL LINE DEVELOPMENT PLATFORM

Jan 30 12:06

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTEXCLUSIVE LICENSE AGREEMENT FOR BA2101 IN THE TREATMENT OF RESPIRATORY SYSTEM DISEASES

Jan 26 22:16